Press release
PEGylated Proteins Global Market Report 2024 - By Share, Size, Demand And Trends, Forecast To 2033
PEGylated Proteins Market
As per the report, the PEGylated proteins market size has grown rapidly in recent years. It will grow from $1.29 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The PEGylated proteins market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16145&type=smp
Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market
The increasing prevalence rate of lifestyle diseases is expected to propel the growth of the PEGylated proteins market going forward. Lifestyle diseases refer to health conditions primarily caused by unhealthy habits and lifestyle choices such as poor diet, lack of physical activity, and smoking. Lifestyle diseases are on the rise due to a combination of factors such as less physical activity, unhealthier diets high in processed foods, and increased stress. PEGylated proteins are utilized in treating lifestyle diseases by enhancing the efficacy, duration, and targeted delivery of therapeutic agents for conditions including cardiovascular diseases, diabetes, and certain cancers. For instance, in October 2022, according to the World Heart Federation (WHF), a Switzerland-based non-governmental organization, the number of cardiovascular disease deaths is projected to rise from an estimated 18.9 million in 2020 to over 22.2 million in 2030. Additionally, in December 2021, according to the IDF Diabetes Atlas 10th Edition report published by the International Diabetes Federation, a Belgium-based diabetes community, 537 million adults aged 20 to 79 years worldwide were currently diagnosed with diabetes, representing 1 in 10 individuals. Therefore, the increasing prevalence rate of lifestyle diseases is driving the growth of the PEGylated proteins market.
Developments In Drug Delivery Mechanisms For Driving Biomedical Innovation
Major companies operating in the PEGylated protein market are developing innovative products, such as PEGylation reagents, to gain a competitive edge in the market. PEGylation reagents refer to chemical compounds that attach polyethylene glycol (PEG) chains to biomolecules, altering their properties for various biomedical applications. For instance, in May 2023, Creative Enzymes, a US-based supplier of food additives and enzymes, launched DSPE-PEG-Maleimide for targeted drug delivery. DSPE-PEG-Maleimide (DSPE-PEG-MAL) is a linear heterobifunctional PEGylation reagent containing DSPE phospholipids and maleimide. It is a useful self-assembly reagent that can be used to prepare PEGylated liposomes or micelles, and it also provides thiol or cysteine reactive maleimide groups. It is often used in targeted drug delivery.
The PEGylated proteins market covered in this report is segmented -
1) By Product: Consumable And Services, PEGylation Kits And Reagents, Monofunctional Linear PEGs, Bifunctional PEGs, Services, Other Products
2) By Protein Type: Colony Stimulating Factors, Interferons, Erythropoietin, Recombinant Factor VII, Other Protein Types
3) By Application: Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, Other Applications
4) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16145&type=discount
Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.
Contents of the report:
1. Executive Summary
2. PEGylated Proteins Market Report Structure
3. PEGylated Proteins Market Trends And Strategies
4. PEGylated Proteins Market - Macro Economic Scenario
5. PEGylated Proteins Market Size And Growth
…..
27. PEGylated Proteins Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/pegylated-proteins-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PEGylated Proteins Global Market Report 2024 - By Share, Size, Demand And Trends, Forecast To 2033 here
News-ID: 3584665 • Views: …
More Releases from The Business research company
Event Camera Module Market Landscape to 2034: Key Forces Shaping the Next Decade …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Event Camera Module Industry Market Size Be by 2025?
The market for event camera modules has experienced swift expansion in the past few years. Expectations are to see it rise from $3.82 billion in 2024 to $4.53 billion in 2025, with a compound annual growth rate…
Enterprise Imaging Information Technology (IT) Market Poised to Hit $3.89 Billio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Enterprise Imaging Information Technology (IT) Market Size By 2025?
The size of the enterprise imaging information technology (IT) market has seen significant expansion in the past few years. Its size is predicted to escalate from $2.10 billion in 2024 to $2.39 billion in 2025, reflecting…
Key Trends Reshaping the Electronic Payment Processing Market: Enhancing Transac …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Electronic Payment Processing Market Size Growth Forecast: What to Expect by 2025?
The market size of electronic payment processing has seen a swift surge in recent years. It's set to expand from $100.73 billion in 2024 to $112.36 billion in 2025, boasting a compound annual growth rate (CAGR) of…
Increasing Proliferation Of Internet Of Things (IoT) Devices Fueling The Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Edge Artificial Intelligence Accelerator Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the edge artificial intelligence accelerator has witnessed a significant surge recently. It is projected to expand from $8.28 billion in 2024 to $11.10 billion in 2025, boasting a compound…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
